跳至主要内容
临床试验/CTRI/2025/11/097693
CTRI/2025/11/097693尚未招募不适用

A Clinical Study on the Evaluation of Haridra (Curcuma longa Linn.) Loaded Niosomal Gel for Episiotomy Wound Healing with Special Reference to Vrana Ropana.

Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年11月30日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
to assess the rate and quality of wound healing using Haridra loaded niosomal gel

研究概览

简要总结

This study is single arm single centre pilot study to evaluate the efficacy of Haridra (Curcuma longa Linn)  Loaded Niosomal Gel for 18 months in 30 patients  for Episiotomy wound healing with special refrence to Vrana Ropana

The primary outcomes measures  will be to assess the rate and quality of wound healing using Haridra loaded niosomal gel and to evaluate changes in Redness, Ecchymosis, Discharge , Approximatiion score, and pain (VAS scale) during the healing process

The secondary outcomes measures will be based on to assess the antimicrobial effects of Haridra loaded Niosomal gel

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • •.women age between 18 to 35 who have undergoes normal vaginal delivery with mediolateral episiotomy .primiparous women .Healthy term pregnancy .REEDA score equivalent or less than 4 .who can attain hospital for a regular follow up .patients who give written informed consent for the clinical trial .singleton vaginal delivery.

排除标准

  • •.women of age less than 18 years and more than 35 years .episiotomy wound infection already present at day 1 .women with intrumental deliveries (foreceps or vaccum assisted) .multiparous women .known case of diabetes mellitus,hypertension , or immunocompromised status .known allergy ,hypersensitivity .post partum complications.

结局指标

主要结局

to assess the rate and quality of wound healing using Haridra loaded niosomal gel

时间窗: Day 1(baseline) ,day 7,day 15 and with additional observation at day 21 and day 30 to evaluate sustained healing and late occuring effect

.to evaluate changes in redness,oedema ,ecchymosis, discharge ,approximation score, and pain (VAS scale) during the healing process

时间窗: Day 1(baseline) ,day 7,day 15 and with additional observation at day 21 and day 30 to evaluate sustained healing and late occuring effect

次要结局

  • to assess the antimicrobial effect of Haridra loaded niosomal gel(Day 1 (baseline), day 7, day 15 and with additional observation at day 21, and day 30 to evaluate sustained healing and late occuring effect)

研究者

发起方
Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Rubab Chaudhary

Kunwar shekhar vijendra ayurved medical college and research centre, Shobhit university ,Gangoh

研究点 (1)

Loading locations...

相似试验